Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Metabolism: Clinical and Experimental
|
November 1, 1977
New evidence for growth hormone modulation by the alpha-adrenergic system in man
I Lancranjan, P Marbach
European Journal of Pharmacology
|
June 1, 1978
Some biological properties of an "irreversible" antagonist of neurohypophyseal hormones, deamino-[Phe(4-BrCH2CONH)2]-oxytocin, and its isosteric analogue, deamino-[Phe(4-CH3CH2CONH)2]-oxytocin
V Pliska, P Marbach
Journal of Immunological Methods
|
January 4, 1993
A time-resolved fluoroimmunoassay for human insulin based on two monoclonal antibodies
M J Storch, P Marbach, L Kerp
Metabolism: Clinical and Experimental
|
August 1, 1996
Sandostatin LAR (microencapsulated octreotide acetate) in acromegaly: pharmacokinetic and pharmacodynamic relationships
P Grass, P Marbach, C Bruns, et al.
The Journal of Pharmacy and Pharmacology
|
November 19, 1997
Poly(alkyl cyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue
C Damgé, J Vonderscher, P Marbach, et al.
Experientia
|
March 15, 1977
[2-o-Iodotyrosine]-oxytocin and [2-o-methyltyrosine]-oxytocin: basic pharmacology and comments on their potential use in binding studies
V Pliska, P Marbach, J Vasák, et al.
Clinical Chemistry
|
November 1, 1975
Sodium iodoacetate as an antiglycolytic agent in blood samples
E P Marbach, M McLean, M Scharn, et al.
Digestion
|
January 1, 1993
From somatostatin to Sandostatin: pharmacodynamics and pharmacokinetics
P Marbach, U Briner, M Lemaire, et al.
European Journal of Clinical Investigation
|
August 1, 1992
Renal reserve filtration capacity in growth hormone deficient subjects
R P Dullaart, S Meijer, P Marbach, et al.
Metabolism: Clinical and Experimental
|
September 1, 1992
From somatostatin to sandostatin: pharmacodynamics and pharmacokinetics
P Marbach, U Briner, M Lemaire, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Metabolism: Clinical and Experimental
|
November 1, 1977
New evidence for growth hormone modulation by the alpha-adrenergic system in man
I Lancranjan, P Marbach
European Journal of Pharmacology
|
June 1, 1978
Some biological properties of an "irreversible" antagonist of neurohypophyseal hormones, deamino-[Phe(4-BrCH2CONH)2]-oxytocin, and its isosteric analogue, deamino-[Phe(4-CH3CH2CONH)2]-oxytocin
V Pliska, P Marbach
Journal of Immunological Methods
|
January 4, 1993
A time-resolved fluoroimmunoassay for human insulin based on two monoclonal antibodies
M J Storch, P Marbach, L Kerp
Metabolism: Clinical and Experimental
|
August 1, 1996
Sandostatin LAR (microencapsulated octreotide acetate) in acromegaly: pharmacokinetic and pharmacodynamic relationships
P Grass, P Marbach, C Bruns, et al.
The Journal of Pharmacy and Pharmacology
|
November 19, 1997
Poly(alkyl cyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue
C Damgé, J Vonderscher, P Marbach, et al.
Experientia
|
March 15, 1977
[2-o-Iodotyrosine]-oxytocin and [2-o-methyltyrosine]-oxytocin: basic pharmacology and comments on their potential use in binding studies
V Pliska, P Marbach, J Vasák, et al.
Clinical Chemistry
|
November 1, 1975
Sodium iodoacetate as an antiglycolytic agent in blood samples
E P Marbach, M McLean, M Scharn, et al.
Digestion
|
January 1, 1993
From somatostatin to Sandostatin: pharmacodynamics and pharmacokinetics
P Marbach, U Briner, M Lemaire, et al.
European Journal of Clinical Investigation
|
August 1, 1992
Renal reserve filtration capacity in growth hormone deficient subjects
R P Dullaart, S Meijer, P Marbach, et al.
Metabolism: Clinical and Experimental
|
September 1, 1992
From somatostatin to sandostatin: pharmacodynamics and pharmacokinetics
P Marbach, U Briner, M Lemaire, et al.
Page
of 4